Targetable genomic alterations such as EGFR mutations and ALK/ROS1 translocations that are pathognomonic for LUAD have been reported in some LUSC patients and SCLC patients39,40, suggesting that the histology is not primarily determined by genomic features. Here, ALK is linked to small cell lung carcinoma.